Postpartum low-dose esketamine aids moms with prenatal depression

A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ.

Leave A Comment

Your email address will not be published. Required fields are marked *